Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Overall Survival, Adverse Events, and Economic Burden in Medicare Patients with Chronic Lymphocytic Leukemia Receiving Cancer-Directed Therapy

Ravi K Goyal, MS, Saurabh P Nagar, MS, Shaum M Kabadi, PhD MPH, Keith L Davis, MA, Hannah Le, PharmD, MPH, James A Kaye, MD

Blood (2019) 134 (Supplement_1): 796.

https://doi.org/10.1182/blood-2019-122842

Published: 2019

Journal Articles

Overall Survival, Adverse Events, and Economic Burden in Medicare-Insured Patients with Mantle Cell Lymphoma Receiving Cancer-Directed Therapy

Shaum M Kabadi, PhD MPH, Ravi K Goyal, MS, Saurabh P Nagar, MS, Keith L Davis, MA, Hannah Le, PharmD, MPH, Xianglin L Du, MB, MS, PhD, Preetesh Jain, MBBS,MDDM,PhD, Michael L. Wang, MD, Jorge Enrique Romaguera, MD, James A Kaye, MD

Blood (2019) 134 (Supplement_1): 63.

https://doi.org/10.1182/blood-2019-122841

Published: 2019

Journal Articles

Treatment Patterns, Adverse Events, and Economic Burden in a Privately Insured Population of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia in the United States

Shaum Kabadi, PhD MPH, Ravi K Goyal, MS, Saurabh P Nagar, James A Kaye, MD, Keith L Davis, Anthony R Mato, MD

Blood (2018) 132 (Supplement 1): 3557.

https://doi.org/10.1182/blood-2018-99-114735

Published: 2018

Journal Articles

Real-World Treatment Patterns and Associated Adverse Events Among Patients with Mantle Cell Lymphoma (MCL) in the United States

Ravi Goyal, MS, Sudeep Karve, PhD, Saurabh Nagar, James A. Kaye, MD, Anthony R. Mato, MD

Blood (2017) 130 (Supplement 1): 5650.

https://doi.org/10.1182/blood.V130.Suppl_1.5650.5650

Published: 2017

Journal Articles

Adverse Events, Resource Use, and Economic Burden in Patients with Mantle Cell Lymphoma in the United States

Sudeep Karve, PhD, Saurabh Nagar, Ravi Goyal, MS, James A. Kaye, MD, Anthony R. Mato, MD

Blood (2017) 130 (Supplement 1): 3442.

https://doi.org/10.1182/blood.V130.Suppl_1.3442.3442

Published: 2017

Journal Articles

Real-World Clinical Outcomes By Cytogenetic Risk Category in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in France

Huamao Mark Lin, PhD, Keith L Davis, MA, James A. Kaye, MD DrPH, Katarina Luptakova, Lu Gao, PhD(candidate), Saurabh Nagar, MS, Brian Seal, RPh, MBA, PhD, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 4784.

https://doi.org/10.1182/blood.V128.22.4784.4784

Published: 2016

Journal Articles

Real-World Treatment Patterns and Health Care Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in France

Huamao Mark Lin, PhD, Keith L Davis, MA, James A. Kaye, MD DrPH, Katarina Luptakova, Lu Gao, PhD(candidate), Saurabh Nagar, MS, Brian Seal, RPh, MBA, PhD, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 5945.

https://doi.org/10.1182/blood.V128.22.5945.5945

Published: 2016

Journal Articles

Real-World Treatment Patterns in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in the United Kingdom

Huamao Mark Lin, PhD, Keith L Davis, MA, James A. Kaye, MD DrPH, Katarina Luptakova, Saurabh Nagar, MS, Brian Seal, RPh, MBA, PhD

Blood (2016) 128 (22): 5947.

https://doi.org/10.1182/blood.V128.22.5947.5947

Published: 2016

Journal Articles

Same-Day Administration of Pegfilgrastim Following Myelosuppressive Chemotherapy: Practices and Rationale

Christina Darden, Mark A. Price, James A. Kaye, MD DrPH, Bintu Sherif, Sarah Marion, Spiros Tzivelekis, MSc, Jacob Garcia, MD, David Chandler

Blood (2015) 126 (23): 5585.

https://doi.org/10.1182/blood.V126.23.5585.5585

Published: 2015

Journal Articles

Increased Incidence of Thromboembolic Event Rates in Patients Diagnosed with Polycythemia Vera: Results from an Observational Cohort Study

Ravi K Goyal, MS, BPharm, Keith L Davis, MA, Isabelle Cote, PhD, Nadjat Mounedji, MD, James A. Kaye, MD DrPH

Blood (2014) 124 (21): 4840.

https://doi.org/10.1182/blood.V124.21.4840.4840

Published: 2014

Journal Articles

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Keith L Davis, MA, James A. Kaye, MD DrPH, Isabelle Cote, PhD, Haitao Gao, Julian Perez Ronco, MD, Raafat Seifeldin, Pharm D, MS, PhD, Estella Mendelson, BSRN, MBA

Blood (2014) 124 (21): 1857.

https://doi.org/10.1182/blood.V124.21.1857.1857

Published: 2014

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Annete Njue, PhD, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5099.

https://doi.org/10.1182/blood.V122.21.5099.5099

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Ann Colosia, PhD, Peter C Trask, PhD, MPH, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Annete Njue, PhD, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, Rodrigo Ruiz-Soto, MD, MSc, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5104.

https://doi.org/10.1182/blood.V122.21.5104.5104

Published: 2013

Journal Articles

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Rachel Lee Police, MPH, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Annete Njue, PhD, Jianmin Wang, PhD, MD, Sherrill Elizabeth, MS, James A. Kaye, MD, DrPH, Rodrigo Ruiz-Soto, MD, MSc, Mehdi Hamadani, MD

Blood (2013) 122 (21): 5106.

https://doi.org/10.1182/blood.V122.21.5106.5106

Published: 2013

Journal Articles

Treatment Response Patterns and Related Prognostic Indicators in Chronic Myeloid Leukemia (CML) Patients: A Multi-Country Medical Record Review Study

Peter C Trask, PhD, MPH, Debanjali Mitra, MA, MBA, Shrividya Iyer, PhD, Sean D Candrilli, PhD, James A. Kaye, MD, DrPH

Blood (2011) 118 (21): 3131.

https://doi.org/10.1182/blood.V118.21.3131.3131

Published: 2011

Journal Articles

Effect of Age on Neutropenia-Related Hospitalization in Non-Hodgkin's Lymphoma Patients Receiving Myelosuppressive Chemotherapy

Henry J Henk, PhD, Robert G Deeter, PharmD, James A. Kaye, MD, DrPH, Laura K Becker, MS, Jason C Legg, PhD, Kenneth J Rothman, DrPH

Blood (2011) 118 (21): 2082.

https://doi.org/10.1182/blood.V118.21.2082.2082

Published: 2011

NARROW

Overall Survival, Adverse Events, and Economic Burden in Medicare Patients with Chronic Lymphocytic Leukemia Receiving Cancer-Directed Therapy

Overall Survival, Adverse Events, and Economic Burden in Medicare-Insured Patients with Mantle Cell Lymphoma Receiving Cancer-Directed Therapy

Treatment Patterns, Adverse Events, and Economic Burden in a Privately Insured Population of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia in the United States

Real-World Treatment Patterns and Associated Adverse Events Among Patients with Mantle Cell Lymphoma (MCL) in the United States

Adverse Events, Resource Use, and Economic Burden in Patients with Mantle Cell Lymphoma in the United States

Real-World Clinical Outcomes By Cytogenetic Risk Category in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in France

Real-World Treatment Patterns and Health Care Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in France

Real-World Treatment Patterns in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in the United Kingdom

Same-Day Administration of Pegfilgrastim Following Myelosuppressive Chemotherapy: Practices and Rationale

Increased Incidence of Thromboembolic Event Rates in Patients Diagnosed with Polycythemia Vera: Results from an Observational Cohort Study

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Treatment Response Patterns and Related Prognostic Indicators in Chronic Myeloid Leukemia (CML) Patients: A Multi-Country Medical Record Review Study

Effect of Age on Neutropenia-Related Hospitalization in Non-Hodgkin's Lymphoma Patients Receiving Myelosuppressive Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only